Canh Hiep Nguyen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 5 | 2024 | 562 | 1.610 |
Why?
|
| Bile Duct Neoplasms | 4 | 2024 | 614 | 0.870 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2023 | 303 | 0.690 |
Why?
|
| Hepatitis, Autoimmune | 2 | 2018 | 173 | 0.600 |
Why?
|
| Gallbladder Neoplasms | 1 | 2019 | 190 | 0.580 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 292 | 0.570 |
Why?
|
| Hepatitis, Chronic | 1 | 2017 | 53 | 0.560 |
Why?
|
| Liver | 3 | 2021 | 7571 | 0.300 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1960 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8623 | 0.210 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 81 | 0.210 |
Why?
|
| Interleukin-23 | 1 | 2024 | 202 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6359 | 0.190 |
Why?
|
| Butyrates | 1 | 2012 | 164 | 0.190 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11657 | 0.180 |
Why?
|
| Erythroid Cells | 1 | 2012 | 237 | 0.180 |
Why?
|
| Histocytochemistry | 1 | 2021 | 697 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 2329 | 0.170 |
Why?
|
| Glutamine | 1 | 2012 | 575 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 456 | 0.150 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2018 | 142 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2024 | 790 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2024 | 1895 | 0.140 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 4356 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2019 | 484 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 1 | 2018 | 340 | 0.130 |
Why?
|
| Necrosis | 2 | 2018 | 1614 | 0.130 |
Why?
|
| Japan | 2 | 2018 | 1418 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2018 | 572 | 0.130 |
Why?
|
| Retinal Vessels | 1 | 2021 | 863 | 0.120 |
Why?
|
| Cholangitis | 1 | 2016 | 110 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 608 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 951 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2018 | 855 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2019 | 1968 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 2631 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2017 | 599 | 0.110 |
Why?
|
| Hepatocytes | 2 | 2018 | 1246 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2012 | 2060 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 1104 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2801 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2252 | 0.090 |
Why?
|
| Acute Disease | 2 | 2018 | 7240 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2903 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3698 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59548 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6779 | 0.060 |
Why?
|
| Phenotype | 1 | 2021 | 16722 | 0.050 |
Why?
|
| Luciferases, Renilla | 1 | 2012 | 22 | 0.050 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2012 | 53 | 0.050 |
Why?
|
| alpha-Globins | 1 | 2012 | 20 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2012 | 71 | 0.050 |
Why?
|
| Adult | 5 | 2024 | 223305 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 147 | 0.050 |
Why?
|
| Macrophages | 1 | 2017 | 5784 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 117 | 0.050 |
Why?
|
| beta-Globins | 1 | 2012 | 111 | 0.050 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 306 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12985 | 0.050 |
Why?
|
| K562 Cells | 1 | 2012 | 644 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 29959 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15425 | 0.040 |
Why?
|
| Heme | 1 | 2012 | 316 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 171344 | 0.040 |
Why?
|
| Humans | 10 | 2024 | 766812 | 0.040 |
Why?
|
| Glutathione | 1 | 2012 | 589 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 694 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15912 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 223267 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1525 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2024 | 923 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 326 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1751 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81657 | 0.030 |
Why?
|
| Male | 4 | 2024 | 364154 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5749 | 0.030 |
Why?
|
| Female | 4 | 2024 | 396532 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 59939 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2846 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 88902 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5795 | 0.020 |
Why?
|
| Fibrosis | 1 | 2018 | 2078 | 0.020 |
Why?
|
| Cell Line | 1 | 2024 | 15564 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10451 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4559 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 13276 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2024 | 23618 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21527 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65286 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74889 | 0.010 |
Why?
|